Balance Sheet Details (Tables)

3 Months Ended

Mar. 31, 2021

Balance Sheet Related Disclosures [Abstract]

Schedule of Inventory

The following table provides details of our inventory balance:

(In thousands)	March 31, 2021		December 31, 2020
Raw materials	$	659	$	391
Work in process	755		243
Finished goods	910		392
Total	$	2,324	$	1,026

Details of accrued and other current liabilities

The following table provides details of accrued and other current liabilities:

(In thousands)	March 31, 2021		December 31, 2020
Accrued clinical trial expenses	$	14,405	$	16,477
Accrued compensation	7,135		10,917
Accrued milestone payment	—		15,000
Other accrued liabilities	9,209		12,570
Total	$	30,749	$	54,964